반응식
[CH3:1][C@@H:2]1[CH2:11][C:10]2[C:5](=[CH:6][CH:7]=[C:8]([C@H:12]3[O:17][CH2:16][C@@H:15]4[CH2:18][N:19]([C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23])[CH2:20][CH2:21][N:14]4[CH2:13]3)[CH:9]=2)[C:4](=[O:29])[O:3]1.C[C@@H]1CC2C(=CC=C([C@@H]3OC[C@@H]4CN(C(OC(C)(C)C)=O)CCN4C3)C=2)C(=O)O1.BrC1C=C2C(=CC=1)C(=O)O[C@H](C)C2.OC[C@@H]1NCCN(C(OC(C)(C)C)=O)C1>>[CH3:1][C@@H:2]1[CH2:11][C:10]2[C:5](=[CH:6][CH:7]=[C:8]([C@@H:12]3[O:17][CH2:16][C@H:15]4[CH2:18][N:19]([C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23])[CH2:20][CH2:21][N:14]4[CH2:13]3)[CH:9]=2)[C:4](=[O:29])[O:3]1참가 물질
5
반응물 4
생성물 1
실험 절차
8G and 8H were prepared in a similar manner as 8A and 8B except (3R)-6-Bromo-3-methyl-3,4-dihydro-1H-isochromen-1-one and tert-butyl (3R)-3-(hydroxymethyl)piperazine-1-carboxylate were used as the starting materials. The cis/trans mixture was purified via chiral HPLC (20% 2:1 MeOH:MeCN/CO2) on OJ column. The slower eluting diastereomer was the trans isomer: 8G LC-MS: (M+1)+403; 8H: LC-MS: (M+1)+403.
후처리
- customThe cis/trans mixture was purified via chiral HPLC (20% 2:1 MeOH:MeCN/CO2) on OJ column
- washThe slower eluting diastereomer
출처 및 근거
- ORD 기록
- ord-ba51efd342f44bde8f6b143c49164156
- 출처 데이터셋
- uspto-grants-2015_12
- 특허 번호
- US09206199B2
연결된 노트
불러오는 중…